“We need global awareness of lipoprotein (a),” Tremulis tells Fortune. “High lipoprotein (a) impacts one in five globally…And ...
Inadequate magnesium intake is a critical factor in cardiovascular disease development, necessitating increased awareness and ...
But weight loss alone does not explain the drugs’ benefits. Both Holst and Sattar pointed to a discontinued GLP-1 drug once ...
NewAmsterdam is singing data from its Broadway heart disease trial, hailing another phase 3 win for its cholesterol-busting ...
Many individuals seeking asylum in the United States show increased stress and pain symptoms that are associated with indications of cardiovascular disease.